Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

3 Feb 2016 16:50

RNS Number : 0029O
Reckitt Benckiser Group PLC
03 February 2016
 

RECKITT BENCKISER GROUP PLC

 

TRANSACTION IN OWN SECURITIES

 

 

 

Reckitt Benckiser Group plc ("RB") announces today that it has purchased the following number of its ordinary shares of 10p each (the "Ordinary Shares") on the London Stock Exchange from Morgan Stanley & Co. International PLC ("Morgan Stanley"). Such purchase was effected pursuant to irrevocable instructions issued by RB on 30 December 2015, as announced on 30 December 2015:

 

Ordinary Shares

 

Date of purchase:

03 February 2016

Number of Ordinary Shares purchased:

35,959

Price per share:

£62.9048

 

RB intends to hold the purchased shares in treasury.

 

Following the above transaction, RB holds 29,426,873 Ordinary Shares in treasury and has 707,108,306 Ordinary Shares in issue (excluding treasury shares).

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Contact:

Christine Logan

Company Secretary

Reckitt Benckiser Group plc

01753 217800

 

 

 

About RB:

 

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.

 

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

 

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.

 

For more information visit www.rb.com 

 

*RB is the trading name of the Reckitt Benckiser group of companies

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSQXLFBQLFZBBV
Date   Source Headline
5th Mar 20194:30 pmRNSDirector Declaration
4th Mar 201911:43 amRNSDirector/PDMR Shareholding
1st Mar 20197:30 amRNSTotal Voting Rights
28th Feb 201911:16 amRNSDirector/PDMR Shareholding
20th Feb 20193:19 pmRNSDirector/PDMR Shareholding
18th Feb 20197:00 amRNSFull Year Results 2018
1st Feb 20198:44 amRNSTotal Voting Rights
16th Jan 20197:05 amRNSRakesh Kapoor to retire as CEO by end of 2019
4th Jan 201911:00 amRNSDirectorate Change
2nd Jan 20192:23 pmRNSDirectorate Change
31st Dec 20181:12 pmRNSTotal Voting Rights
27th Dec 20184:41 pmRNSSecond Price Monitoring Extn
27th Dec 20184:35 pmRNSPrice Monitoring Extension
13th Dec 20189:43 amRNSDirectorate Change
3rd Dec 201810:09 amRNSTotal Voting Rights
19th Nov 201810:11 amRNSDirector Declaration
9th Nov 201811:56 amRNSDirectorate Change
31st Oct 201812:18 pmRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSQ3 2018: Trading Update
1st Oct 20185:17 pmRNSDirector/PDMR Shareholding
1st Oct 201812:34 pmRNSTotal Voting Rights
31st Aug 20184:46 pmRNSTotal Voting Rights
31st Aug 20184:00 pmRNSDirectorate Change
8th Aug 20182:32 pmRNSHolding(s) in Company
1st Aug 20189:43 amRNSTotal Voting Rights
27th Jul 20187:00 amRNSHalf Year Results
2nd Jul 201810:01 amRNSTotal Voting Rights
26th Jun 201810:15 amRNSDirectorate Change
7th Jun 20184:55 pmRNSDirector/PDMR Shareholding
1st Jun 201811:28 amRNSTotal Voting Rights
31st May 20184:35 pmRNSPrice Monitoring Extension
29th May 20183:11 pmRNSDirector/PDMR Shareholding
25th May 20185:34 pmRNSDirector/PDMR Shareholding
9th May 20182:00 pmRNSHolding(s) in Company
8th May 20182:00 pmRNSDirector/PDMR Shareholding
4th May 20184:27 pmRNSDirectorate Change
3rd May 20183:17 pmRNSResult of AGM
1st May 20181:00 pmRNSChange in Director's Details
1st May 20189:30 amRNSTotal Voting Rights
20th Apr 20187:00 amRNSQ1 2018 Trading Update
18th Apr 20182:00 pmRNSHolding(s) in Company
3rd Apr 20189:00 amRNSTotal Voting Rights
28th Mar 20185:23 pmRNSAnnual Financial Report
22nd Mar 20187:00 amRNSOffer Talks Terminated
19th Mar 201811:00 amRNSDirectorate Change
1st Mar 201810:59 amRNSTotal Voting Rights
19th Feb 20187:00 amRNSFinal Results
1st Feb 20189:19 amRNSTotal Voting Rights
2nd Jan 201810:07 amRNSTotal Voting Rights
1st Dec 201710:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.